261 related articles for article (PubMed ID: 11303793)
1. Increased expression of the normal cellular isoform of prion protein in inclusion-body myositis, inflammatory myopathies and denervation atrophy.
Zanusso G; Vattemi G; Ferrari S; Tabaton M; Pecini E; Cavallaro T; Tomelleri G; Filosto M; Tonin P; Nardelli E; Rizzuto N; Monaco S
Brain Pathol; 2001 Apr; 11(2):182-9. PubMed ID: 11303793
[TBL] [Abstract][Full Text] [Related]
2. Creutzfeldt-Jakob disease and inclusion body myositis: abundant disease-associated prion protein in muscle.
Kovacs GG; Lindeck-Pozza E; Chimelli L; Araújo AQ; Gabbai AA; Ströbel T; Glatzel M; Aguzzi A; Budka H
Ann Neurol; 2004 Jan; 55(1):121-5. PubMed ID: 14705121
[TBL] [Abstract][Full Text] [Related]
3. The prion protein in human neuromuscular diseases.
Kovács GG; Kalev O; Gelpi E; Haberler C; Wanschitz J; Strohschneider M; Molnár MJ; László L; Budka H
J Pathol; 2004 Nov; 204(3):241-7. PubMed ID: 15476279
[TBL] [Abstract][Full Text] [Related]
4. Prion diseases and emerging prion diseases.
Yokoyama T; Mohri S
Curr Med Chem; 2008; 15(9):912-6. PubMed ID: 18473798
[TBL] [Abstract][Full Text] [Related]
5. Two-dimensional mapping of three phenotype-associated isoforms of the prion protein in sporadic Creutzfeldt-Jakob disease.
Zanusso G; Righetti PG; Ferrari S; Terrin L; Farinazzo A; Cardone F; Pocchiari M; Rizzuto N; Monaco S
Electrophoresis; 2002 Jan; 23(2):347-55. PubMed ID: 11840543
[TBL] [Abstract][Full Text] [Related]
6. Involvement of clusterin and the aggresome in abnormal protein deposits in myofibrillar myopathies and inclusion body myositis.
Ferrer I; Carmona M; Blanco R; Moreno D; Torrejón-Escribano B; Olivé M
Brain Pathol; 2005 Apr; 15(2):101-8. PubMed ID: 15912881
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous PrPC metabolism in skeletal muscle cells.
Massimino ML; Ferrari J; Sorgato MC; Bertoli A
FEBS Lett; 2006 Feb; 580(3):878-84. PubMed ID: 16430889
[TBL] [Abstract][Full Text] [Related]
8. Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies.
Mirabella M; Alvarez RB; Bilak M; Engel WK; Askanas V
J Neuropathol Exp Neurol; 1996 Jul; 55(7):774-86. PubMed ID: 8965093
[TBL] [Abstract][Full Text] [Related]
9. Isolation of soluble and insoluble PrP oligomers in the normal human brain.
Xiao X; Yuan J; Zou WQ
J Vis Exp; 2012 Oct; (68):. PubMed ID: 23070047
[TBL] [Abstract][Full Text] [Related]
10. Inducible overexpression of wild-type prion protein in the muscles leads to a primary myopathy in transgenic mice.
Huang S; Liang J; Zheng M; Li X; Wang M; Wang P; Vanegas D; Wu D; Chakraborty B; Hays AP; Chen K; Chen SG; Booth S; Cohen M; Gambetti P; Kong Q
Proc Natl Acad Sci U S A; 2007 Apr; 104(16):6800-5. PubMed ID: 17420473
[TBL] [Abstract][Full Text] [Related]
11. Primary myopathy and accumulation of PrPSc-like molecules in peripheral tissues of transgenic mice expressing a prion protein insertional mutation.
Chiesa R; Pestronk A; Schmidt RE; Tourtellotte WG; Ghetti B; Piccardo P; Harris DA
Neurobiol Dis; 2001 Apr; 8(2):279-88. PubMed ID: 11300723
[TBL] [Abstract][Full Text] [Related]
12. Abnormal accumulation of prion protein mRNA in muscle fibers of patients with sporadic inclusion-body myositis and hereditary inclusion-body myopathy.
Sarkozi E; Askanas V; Engel WK
Am J Pathol; 1994 Dec; 145(6):1280-4. PubMed ID: 7992832
[TBL] [Abstract][Full Text] [Related]
13. Amyloid-beta42 is preferentially accumulated in muscle fibers of patients with sporadic inclusion-body myositis.
Vattemi G; Nogalska A; King Engel W; D'Agostino C; Checler F; Askanas V
Acta Neuropathol; 2009 May; 117(5):569-74. PubMed ID: 19280202
[TBL] [Abstract][Full Text] [Related]
14. Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy.
Askanas V; Engel WK; Yang CC; Alvarez RB; Lee VM; Wisniewski T
Am J Pathol; 1998 Apr; 152(4):889-95. PubMed ID: 9546349
[TBL] [Abstract][Full Text] [Related]
15. Acidic pH and detergents enhance in vitro conversion of human brain PrPC to a PrPSc-like form.
Zou WQ; Cashman NR
J Biol Chem; 2002 Nov; 277(46):43942-7. PubMed ID: 12161431
[TBL] [Abstract][Full Text] [Related]
16. Molecular Subtyping of PrP
Klug GM; Lewis V; Collins SJ
Methods Mol Biol; 2017; 1658():347-354. PubMed ID: 28861800
[TBL] [Abstract][Full Text] [Related]
17. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
Sasaki K; Minaki H; Iwaki T
J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
[TBL] [Abstract][Full Text] [Related]
18. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
[TBL] [Abstract][Full Text] [Related]
19. [Mechanisms of prion transmission].
Sakaguchi S
Nihon Rinsho; 2007 Aug; 65(8):1391-5. PubMed ID: 17695274
[TBL] [Abstract][Full Text] [Related]
20. Update on Creutzfeldt-Jakob disease.
Mallucci G; Collinge J
Curr Opin Neurol; 2004 Dec; 17(6):641-7. PubMed ID: 15542971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
